SREBP-2 promotes cancer progression through the mevalonate-Akt pathway in non-small cell lung cancer
Wenjie You(Shanghai Medical College of Fudan University), Haiquan Chen(Shanghai Medical College of Fudan University)
Cited by 1
Related Papers
Mast cells boost anti-tumor potency of MAIT cells via inflammasome-dependent secretion of IL-18
|Nature Communications|2025|14